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Introduction: Patients with COPD are known to be limited in their performance of activities of
daily life (ADL). This observational study aims to investigate the ventilatory and metabolic
demand of ADL in home settings of patients and evaluate possible mechanisms involved in
physiological limitation during ADL in COPD.
Methods: In their home settings, 21 stable patients with COPD (GOLD IIeIV, mean FEV1 43%
predicted) were asked to perform their most dyspnea causing activities at their usual pace
until symptoms discouraged further performance. Ten healthy control subjects, matched for
age and gender, performed comparable activities. Ventilatory and metabolic demands of
the ADL were studied using a portable breath-by-breath system.
Results: Compared with healthy controls, ADL time was shorter in patients (530  38 s vs.
318  37 s respectively) and activities resulted in important complaints of dyspnea. Oxygen
consumption ( _VO2) during the activities was higher in patients compared to healthy subjects
(957  51 vs. 768  63 mL/min resp.). Ventilatory demand ( _VE) for comparable activity (at iso-
_VO2) was higher in patients and went together with complaints of dyspnea in patients, but not
in healthy subjects. Ventilatory constraints like low ventilatory reserve and inspiratory reserve
volume and dynamic hyperinflation occurred in more than 80% of the patients, especially in
(very) severe patients.
Conclusion: Patients with COPD experience limitations in the performance of ADL, which lead
to reductions in ADL time and dyspnea complaints. There appears to be an important role for
ventilatory limitations, which become more prominent as disease progresses.
ª 2010 Elsevier Ltd. All rights reserved.niversity Nijmegen Medical Centre, Dept. of Pulmonary Diseases (454), PO. Box 9101, 6500 HB
246859568; fax: þ31 246859531.
mcn.nl (AJMC Lahaije).
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Physiology of ADL in COPD patients 1153Introduction
Exertional dyspnea during activities of daily life (ADL) is the
main complaint in patients with moderate-to-severe
chronic obstructive pulmonary disease (COPD).1 It limits
their exercise capacity as well as their ability to carry out
ADL like self-care (such as bathing, dressing, grooming) and
household activities.2 As a consequence, patients adapt or
reduce such activities,2 which in turn leads to a reduced
quality of life.3 Quantification of physical ADL revealed that
COPD patients spend less time standing and walking in daily
life than healthy elderly individuals.4 More recently it was
shown that reduction in physical activity level occurs
already early in the course of the disease.5 Clinical char-
acteristics such as airway obstruction, distance walked in
6 min and self-reported dyspnea only partly reflected
physical activity.5
This agrees with earlier findings that relationships
between exertional dyspnea, disease severity, exercise
capacity, and ADL are weak.6,7 The poor relations will find
part of their origin in themultifactorial components involved
in exercise limitation in COPD. Not only ventilatory
constraints (including dynamic hyperinflation, ventilatory
limitation, hypoxemia or hypercapnia),9e12 but also imbal-
ance in energy supply and peripheralmuscle dysfunctionmay
play a role.13,14 These mechanisms have been and still are
subject of in-depth studies. Simple armelevation (involved in
many ADLs) resulted in significant increases in metabolic and
ventilatory requirements15 and recently, ventilatory
constraints during maximal upper extremity tests have been
described.16 Yet, the physiology of ADL has not been investi-
gated in detail outside the laboratory setting. To date, the
question whether one or more of the described limitations
also occur during common daily life activities has not been
evaluated to the best of our knowledge.
Recent development of telemetric breath-by-breath
systems17e19 introduced the unique opportunity to investi-
gate physiologic impairments during ADL in real life. The
present observational study investigates the ventilatory and
metabolic demand of ADL in home settings of patients with
COPD. The objective was to evaluate possible mechanisms
involved in physiological limitation during ADL in COPD.
Methods
Subjects
Twenty one stable patients with COPD (GOLD II (n Z 6), III
(n Z 9), IV (n Z 6)), participating in an inpatient rehabil-
itation program, were recruited from the University Lung
Centre Dekkerswald in Groesbeek, the Netherlands.
Patients with oxygen therapy at home, an exacerbation
within 4 weeks before the study, and cardiovascular or
neuromuscular comorbidity that limits performance of ADL
were excluded from the study. Additionally, ten healthy
control subjects, matched for age and gender were
recruited from the patients’ and investigators direct envi-
ronment. Pulmonary function tests were measured within
1 week of the home measurements (see below) in all
participants. Symptom limited incremental cycle exercise
tests were performed within 2 months prior to the homemeasurements. The study was approved by the local
medical ethical committee for human and clinical research
and informed consent was obtained from all subjects.
Study design
At home, spirometric measurements were repeated to
verify whether lung function was stable. Then, patients
were interviewed to identify a top-3 list with ADL that
caused them the most dyspnea. Patients were asked to
focus on the activities they perform regularly, like self-
care, household activities and leisure activities. They were
asked to perform these 3 activities at their usual pace until
symptoms discouraged further performance. Between
every ADL at least 15 min of rest was incorporated and
ventilation ( _VE), heart rate (HR), oxygen uptake ( _VO2) and
respiratory quotient (RQ) had to be returned to baseline
values. Healthy individuals performed the same activities
for at least 10 min. Ventilatory and metabolic demands of
the ADL were studied using a portable breath-by-breath
system (Oxycon Mobile, Viasys Healthcare, Germany) (see
below). For analysis, the mean values of the last minute of
the ADL were used. Subjects were asked to rate their
shortness of breath during ADL using a 10-point Borg scale.
Measurements
Spirometry was performed at the pulmonary function
laboratory and static lung volumes were assessed by the
helium-dilution method (Masterlab, Jaeger, Wu¨rzburg,
Germany). Baseline RV and IC were used in proportion to
total lung capacity (TLC) to reflect static hyperinflation of
the lung.20,21 Single-breath carbon monoxide diffusion
capacity (DLCO) was obtained. A symptom limited bicycle
exercise test was performed to assess peak _VO2 (Oxycon
Pro, Jaeger, Wu¨rzburg, Germany) and the 6-min walk
distance was obtained. All measurements were performed
according to the American Thoracic Society/European
Respiratory Society guidelines.22e24 Reference equations
for the calculation of predicted values were those produced
by the European Community for Coal and Steel.25
During ADL, _VO2, carbon dioxide production ( _VCO2), HR
and minute ventilation ( _VE) were measured continuously.
The ratio of _VO2 and HR was used to reflect the oxygen
pulse (O2/HR) during ADL. Ventilatory reserve (VR) was
calculated as the difference between _VE and maximal
voluntary ventilation (MVV, predicted as 37.5 * FEV1) or as
a percentage of MVV.26
Changes in operational lung volumes were derived from
measurements of inspiratory capacity (IC) with the Oxycon
Mobile during ADL. All patients were instructed on the
performance of the IC manoeuvre. After four consistent
end-expiratory levels, monitored by the real-time display
of tidal breathing, the patient was instructed to inspire to
TLC and then to return to normal breathing. With trained
technicians and encouragement of the patient this has been
found to be a reliable method of tracking acute changes in
lung volume.27 Assuming constant TLC,9,28,29 the IC
manoeuvre then reliably reflects changes in end-expiratory
lung volume (EELV, calculated as TLC-IC). Additional vali-
dation of the measurement of operational lung volumes
1154 AJMC Lahaije et al.during ADL can be found in the on-line supplement. IC was
measured at rest, at 2-min intervals during ADL, and at end
ADL, every time in upright position to avoid any effect of
posture on operational lung volumes. An example of IC
measurement at rest and end ADL is shown in Fig. 1.
Inspiratory reserve volume (IRV) during ADL was calcu-
lated as the difference between IC and tidal volume (VT).
To avoid influence of the IC manoeuvre on VT, a mean VT of
15 s preceding the IC manoeuvre was taken.
Oxycon mobile
The Oxycon Mobile is a portable breath-by-breath system,
consisting of a face mask with turbine volume transducer
and integrated O2 and CO2 electrodes, an integrated Polar
heart rate monitor, a portable measuring and transmitting
unit (total weight  500 g) and a fixed receiving unit. The
measuring and transmitting units can be attached to the
subjects’ back with a harness, so impediment of activities
by wiring is avoided. The advantage of Oxycon Mobile is
that it is light weighted, easy to transfer and therefore
provides the possibility to measure beyond laboratory
situations. The Oxycon Mobile has been validated for
ventilatory and metabolic demand before.19 Calibration
measurements were carried out according to the manu-
facturer’s instructions before each study.
Statistical analysis
Subject characteristics are expressed as mean  standard
deviation. Physiology of the ADL with the highest dyspneaFigure 1 Measurement of IC during ADL. Changes in operationa
inspiratory capacity (IC). Changes in IC reflect changes in end-expir
baseline, at 2 min intervals during ADL, and at end ADL. Panel A) re
Panel B) reflects the same patient but at the end of 5 min of vacuscore is presented as mean  standard error for each study
group. Differences between groups were tested by Stu-
dent’s t-tests. The most dyspnea causing ADL in COPD were
used to analyze ventilatory mechanics during ADL. Associ-
ations between resting lung function, exercise parameters,
ventilatory constraints, dyspnea and ADL time were
determined using Pearson’s correlation coefficient analysis.
Statistical significance was set at a p < 0.05. Data were
analysed with SPSS 16.0.
Results
Subjects
Anthropometric characteristics and lung function parame-
ters of the participants are presented in Table 1. Anthro-
pometric characteristics were comparable, while lung
function and maximal exercise capacity were reduced in
patients.
Activities of daily life
The ADL that were mentioned in the patient interviews are
listed in Table 2. Vacuum cleaning was mentioned most
frequently in patient’s individual top-3 of most dyspnea
causing activities (14 times in 21 patients). For any activity
in the patient’s top-3 list that could not be measured, e.g.
showering and getting dressed, an alternative was asked
for.
Table 3 lists the physiology of the ADL that caused the
largest increase in Borg score for dyspnea in patients withl lung volumes were derived from measurements of dynamic
atory lung volume (EELVZ TLC-IC). IC was measured at resting
flects the baseline IC of a male COPD patient, 69 yrs, GOLD III.
um cleaning.
Table 1 Subject characteristics.
Healthy subjects COPD patients p-value
N 10 21
Sex, m/f 5/5 12/9 0.709
Age, yrs 60.0  8.2 58.7  9.0 0.704
Height, m 1.71  0.7 1.72  0.1 0.779
Weight, kg 73.9  11.6 78.3  15.4 0.438
BMI 25.2  3.4 26.5  5.4 0.505
Lung function
FEV1, L 3.24  0.9 1.32  0.6 0.001
FEV1, %predicted 113  15 44  20 0.001
VC, %predicted 120  14 91  22 0.001
FEV1/VC, % 75  6 37  13 0.001
TLC, %predicted 102  9 102  18 0.970
RV, %predicted 82  20 131  38 0.001
RV/TLC 0.28  0.06 0.45  0.1 0.001
IC/TLC 0.53  0.08 0.41  0.09 0.001
DLCO, %predicted e 42  16
Exercise capacity
6MWD, m e 436  101
_VO2peak, l/min 2.0  0.6 1.3  0.5 0.001
Values are presented as mean  standard deviation. Spirometric values are measured post bronchodilation. BMI Z body mass index;
FEV1 Z forced expiratory volume in 1sec; VC Z vital capacity; TLC Z total lung capacity; RV Z residual volume; IC Z inspiratory
capacity; DLCOZ diffusion capacity for carbon monoxide; 6MWDZ 6 min walking distance; _VO2peakZ peak oxygen consumption during
incremental exercise testing.
Physiology of ADL in COPD patients 1155COPD. The physiology of comparable ADL in healthy
subjects is also shown. Absolute _VO2 during the activities
was slightly higher in patients compared to healthy subjects
(Fig. 2). Since peak _VO2 in COPD is lower than in healthy
subjects, ADL resulted in higher _VO2 values as percentage
of peak _VO2 in patients compared to healthy subjects.
Within patients, this was modestly associated with higher
Borg score for dyspnea (r Z 0.53, p Z 0.016). The higher




during walking (4e5 kg)
11
Showeringa 6
Putting on socks and shoes 6
Getting dresseda 5
(Un-) loading washing machine 5
Climbing stairs 5
Dish washing 2
Hanging up laundry 2
Window cleaning 2




The numbers represent the number of times an ADL was cited in
the top-3 of most dyspnea causing activities by patients.
a Indicates ADL that could not be measured.compared to healthy (58  3 in COPD vs. 76  3 in healthy,
p  0.001). However, none of the subjects reached maximal
predicted heart rate. Oxygen pulse did not differ between
patients and healthy subjects. RQ remained below 1.0 in all
subjects.
The rate of increase in ( _VE) was similar in both groups
(repeated measures ANOVA), but the ventilatory demand
( _VE) for comparable activity and at iso _VO2 was higher in
patients. This higher ventilatory demand went together
with complaints of dyspnea in patients, but not in healthy
subjects (Fig. 3).
Detailed ventilatory mechanics in the group of COPD
patients are shown in Fig. 4. For clarity, only data of COPD
patients is shown. _VE, VT and breathing frequency (BF)
increased rapidly from the onset of the ADL, and reached
a plateau within 3 min (Fig. 4A, B, C). Additionally, IC and
IRV decreased already in the first minutes (Fig. 4D).
Towards the end of ADL, IC and IRV progressively
decreased.
In a subsequent examination of the data, possible
mechanisms limiting ADL performance were evaluated.
Starting with the ventilatory limitations, 12 patients (57%)
reached a critically low VR (<11 L),26 although in three of
them this did not emerge when VR was expressed as %MVV.
None of the GOLD II patients reached their VR, but most of
the GOLD III-IV patients did. Twelve patients had a rise in
EELV > 0.5 L, reflecting the occurrence of dynamic hyper-
inflation (DH).30 In five of them, this lead to an IRV < 0.5 L,
the theoretical dyspnea limit.10 In another five patients (all
GOLD III-IV) with IRV < 0.5 L, this could not be attributed to
DH (DEELV was <0.5 L).
Based on HR and oxygen pulse, none of the patients or
healthy subjects reached a cardiocirculatory limitation.
Figure 2 Metabolic demand of ADL in patients with COPD
and healthy subjects. Oxygen consumption ( _VO2) (A) and
carbon dioxide production ( _VCO2) (B) during the most dysp-
nea causing ADL in patients and in comparable activities in
healthy subjects. Numbers in top of panel A) reflect the
number of patients at each time point. ADL time is shorter in
patients than in healthy subjects. Values are shown as
mean  SE.
Table 3 Metabolic and ventilatory response during the
last minute of ADL with the highest increase in dyspnea
score.
Controls COPD p-value
ADL time, s 530  38 318  37 0.001
_VO2, mL/min 768  63 968  56 0.039
_VO2, %peak 41  4 86  5 0.001
_VCO2, mL/min 681  58 774  43 0.219
RQ 0.89  0.02 0.80  0.01 0.001
HR, bpm 84  3 105  3 0.001
O2/HR, mL 9.16  0.75 9.23  0.54 0.943
_VE, L/min 21.9  1.7 32.4  2.0 0.001
_VE/MVV, % 19  2 76  5 0.001
VR, L/min 99.7  10.2 16.2  4.5 0.001
DEELV, mL 220  110 617  95 0.001
IRV, mL 2306  200 763  100 0.001
EILV/TLC, % 62  2 88  2 0.001
EELV/TLC, % 44  2 70  2 0.001
Bf, min1 22  2 27  1 0.010
VT, L 1.1  0.1 1.2  0.1 0.673
VT/VC 0.26  0.01 0.33  0.01 0.003
DBorg dyspnea, au 0.3  0.3 3.9  0.3 0.001
DBorg legs/arms, au 0.5  0.5 2.0  0.6 0.075
_VO2 Z oxygen consumption expressed in ml/min or as
percentage of peak oxygen consumption determined in incre-
mental exercise test; _VCO2 Z carbon dioxide production;
RQ Z respiratory quotient; HR Z heart rate; O2/HR Z oxygen
pulse; _VE Z minute ventilation; MVV Z maximal voluntary
ventilation; VRZ ventilatory reserve (predicted _VE e _VE during
ADL); DEELV Z change in end-expiratory lung volume;
IRV Z inspiratory reserve volume; EILV Z end-inspiratory lung
volume; TLC Z total lung capacity; Bf Z breathing frequency;
VT Z tidal volume; VT/VC Z ratio between tidal volume and
vital capacity; DBorg Z change in dyspnoea or fatigue score
rated by Borg scale; au Z arbitrary units.
1156 AJMC Lahaije et al.Three of the 21 patients reached their anaerobic threshold
(AT) as well as 2 of the 10 healthy controls. The patients
that reached AT all had moderate COPD and performed ADL
for longer than 7.5 min. The main complaint and reason to
end ADL in patients was dyspnea. Nevertheless, some
patients (N Z 7) also complained about fatigue of arms or
legs.
Within patients, dyspnea did not correlate with resting
lung function or ventilatory parameters, nor with ADL time.
However, ADL time correlated with baseline IC (r Z 0.62)
and operating lung volumes at end ADL (IRV rZ 0.71; EILV/
TLC r Z 0.62; EELV/TLC r Z 0.54).
Discussion
The present study objectified limitations in the perfor-
mance of ADL in patients with COPD. For the first time,
possible mechanisms of physiological limitation were
evaluated during activities in home setting of patients.
Compared with healthy controls, ADL time was shorter in
patients and activities resulted in important complaintsof dyspnea. This evaluation showed mainly ventilatory
limitations like absence of ventilatory reserve,
a decrease of IRV as well as DH during common ADL in
COPD patients.
In earlier studies, oxygen consumption and ventilatory
demand during ADL in COPD patients were described.31,32
Compared with these earlier studies, we found higher
_VO2%peak and higher _VE/MVV, but this probably can be
attributed to the different settings used in this study. Jeng
et al. reported 75.8% of _VO2peak during walking while
carrying a load of 2 kg.31 In the present study higher %
_VO2peak were reached (w85%), but with carrying 4e5 kg
loads. Velloso et al. studied COPD patients while perform-
ing ADLs with upper extremity.32 Our subjects mainly per-
formed whole body activities, which would explain the
higher _VO2%peak and _VE compared to the former study. In
contrast to our findings, Jeng et al. found no significant
difference in _VO2 between patients and healthy subjects,
which they explained by a slower walking speed in the
COPD group. A higher _VO2peak in our patients suggests that
they might have performed activities with a higher intensity
and/or higher work of breathing, resulting in a higher _VO2
during ADL.
Figure 3 Ventilatory demand and dyspnoea in COPD patients
and healthy subjects. Minute ventilation ( _VE) is shown rela-
tively to either ADL time A) or at iso _VO2 B) during the most
dyspnea causing ADL in COPD patients and in comparable
activities in healthy subjects. Panel C) shows dyspnea intensity
(measured by Borg score) relative to _VE. Ventilatory demand
and exertional dyspnoea intensity are greater throughout ADL
in COPD compared with health. Values are shown as
means  SE.
Physiology of ADL in COPD patients 1157Recently, possible mechanisms limiting exercise
performance in patients with COPD were extensively dis-
cussed by experts in this field.8 It was recognized that
exercise limitation in COPD is multifactorial and that
inadequate energy supply to the respiratory and loco-
motor muscles, lower limb muscle dysfunction and
dynamic hyperinflation all play a role. In that discussion,
Aliverti and Macklam state that energy demands are
increased in COPD because of the higher O2 cost of
breathing,13 which adds to the energy demand of thelocomotor muscles. Indeed, patients in the present study
show higher _VO2 than healthy controls with comparable
activities. To verify whether this might have led to inad-
equate energy supply, the respiratory quotient (RQ) and
AT were assessed in individual patients. RQ (below 1.0 in
all patients and controls) did not indicate a limitation in
energy supply. In three patients, the AT was reached near
the end of ADL. These patients did not complain about
peripheral muscle fatigue and their main reason to stop
was dyspnea. Theoretically, inadequate energy supply
could lead to metabolic acidosis and by consequent
increase in ventilation precipitate DH. However, two of
these three patients did not reach any ventilatory
constraints at all. So although, in these patients, inade-
quate energy supply cannot be ruled out, it did not seem
to play an important role.
It is well known that in many patients a combination of
dyspnea and leg discomfort are given as exercise-limiting
symptom.14 Indeed, some patients also reported an
increase in Borg score for leg or arm fatigue. Due to the
home setting of this study it was unfeasible to objectify
muscle fatigue by measuring lactate or muscle force. These
patients, like the others, claimed that dyspnea was the
main reason to stop ADL. Nevertheless, we cannot fully
exclude that muscle fatigue has played a role in the early
cessation of ADL.
Fig. 3 gives some insight into the ventilatory response
of ADL. It shows that minute ventilation at comparable
_VO2 is higher in patients vs. healthy subjects. Together
with a decreased MVV, the higher ventilatory demand in
patients is likely to lead to ventilatory constraints.
These ventilatory constraints occurred especially in
patients with GOLD stage III-IV as decreased VR and/or
IRV.
DH, which is known to be associated with dyspnea,33 was
present in 12 patients (57%). In this study however, no
association between DH and dyspnea was found. DH
occurred in all GOLD stages, but in GOLD II patients did not
lead to a critically low IRV.10 Severe patients often have
more static hyperinflation.21 Mechanical restriction then
occurs already with little rise of EELV and a critical IRV is
reached earlier.34 Indeed, 67% of GOLD III-IV patients in this
study reached a critical IRV during ADL.
It seems obvious that, in the course of the disease,
ventilatory constraints become more manifest when
structural abnormalities worsen. However, even in
moderate COPD and without obvious ventilatory limita-
tion, patients reduced ADL time because of dyspnea.
Additionally, in other patients ventilatory constraints
occurred after only a few minutes, but patients were able
to continue ADL for several more minutes. This and the
fact that we did not find enough evidence for impaired
energy supply or muscle dysfunction makes it likely that
another factor may also be involved in the limitations in
these patients. Recently, it was suggested that reduced
physical activity in COPD patients is not necessarily
a consequence of pulmonary limitation, but has a behav-
ioural component.35 This contention was based on the
results of a study by Watz et al. who found significant
limitations of physical activity in patients from GOLD
stage II/BODE score 1.5 Such findings, to our opinion, are
relevant and illustrate the complexity to unravel
Figure 4 Ventilatory mechanics during ADL in COPD. Mechanics of the ventilation and also operational lung volumes during ADL in
COPD. A) _VE, ventilation; B) VT, tidal volume; C) BF, breathing frequency; D) operational lung volumes at 2 and 4 min and at end
ADL: total lung capacity (TLC), inspiratory reserve volume (IRV), VT, inspiratory capacity (IC). Ventilatory mechanics show a rapid
increase while IRV and IC decrease from the onset of ADL.
1158 AJMC Lahaije et al.mechanisms contributing to limitations in daily life of
COPD patients.
Several limitations of the present study have to be
addressed. First, the authors realize that by measuring
individually chosen ADL, a great variety in types of ADL
exists. However, since the purpose of this study was to
describe the physiology and limitations in ADL, this is also
the interesting part of the study. Second, because the
Oxycon Mobile is not water resistant and the measuring and
transmitting unit have to be worn in a harness, two of the
frequently mentioned ADLs, e.g. showering and getting
dressed, were not measured. Third, although this new
portable technology enabled us to study daily life activities
within a patients’ home setting, additional information on
for example arterial blood gas concentration is not avail-
able, thus information about gas exchange could not be
included.
In conclusion, this study objectified physiological limi-
tations in ADL in patients with COPD. There appears to be
an important role for ventilatory limitations, which become
more prominent as disease progresses. Especially investi-
gating patients with mild and moderate disease might help
to understand why and when in the course of the disease
physiological limitation begins to have its repercussion in
daily life and/or activity level is reduced.Conflict of interest
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